Vir Biotechnology Inc. Common Stock vs Cactus Inc. Class A Common Stock — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B), while Cactus Inc. Class A Common Stock trades at $62.37 (market cap $5.14B). The key difference: Cactus Inc. Class A Common Stock is far larger — about 2.9× Vir Biotechnology Inc. Common Stock's market cap, and Cactus Inc. Class A Common Stock pays a 0.94% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Cactus Inc. Class A Common Stock for 0 Days on average.
| VIR | WHD | |
|---|---|---|
Market Cap | $1.80B | $5.14B |
Volume | 1,782,836 | 634,348 |
Sector | Health | Energy |
52-Week High | $11.78 | $73.73 |
52-Week Low | $5.12 | $35.26 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.36B | $4.83B |
Dividend Yield | — | 0.94% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →Cactus Inc. designs, manufactures, and rents wellhead and pressure control equipment for oil and gas drilling, completion, and production, operating under the Cactus Wellhead brand.
Read more on WHD →